PubMed Kruse, T., Sewing, S., Jarl Edsberg, M., Fels, J.J., Hastrup, S., Holst-Hansen, T., Karsdal, M.A., Kramer, S.R., Roth, J., Sidelmann, J.J., Sonne, D.P., Teuteberg, K., Vissing, L., & Henriksen, K
An important distinction from the FDA criteria is that the WHO guideline does not extend its recommendation to adults with a BMI between 27 and 30 who have obesity-related conditions
Br J Pharmacol 172(1):6479
The pressure to stay in shape is probably higher than it has ever been, especially online
The researchers saw that, across all therapies, the higher-dose GLP-1 receptor agonists generally demonstrated greater cardiometabolic improvements
Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial